TY  - GEN
AU  - Gallenga,P E
AU  - Lobefalo,L
AU  - Colangelo,L
AU  - Della Loggia,G
AU  - Orzalesi,N
AU  - Velati,P
AU  - Bujtar,E
AU  - Ponte,F
AU  - Damiani,S
AU  - Bucci,M G
AU  - Bonini,S
AU  - Curatola,M R
AU  - Palma,L A
AU  - Bonomi,L
AU  - Tomazzoli Gerosa,L
AU  - Pagliarusco,A
AU  - Milan,E
AU  - Jauch,A
TI  - Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study
SN  - 0030-3755
PY  - 1999///0826
KW  - Acute Disease
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anti-Bacterial Agents
KW  - administration & dosage
KW  - Anti-Infective Agents
KW  - Bacteria
KW  - drug effects
KW  - Child
KW  - Colony Count, Microbial
KW  - Conjunctiva
KW  - microbiology
KW  - Conjunctivitis, Bacterial
KW  - drug therapy
KW  - Double-Blind Method
KW  - Female
KW  - Fluoroquinolones
KW  - Follow-Up Studies
KW  - Haemophilus Infections
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Ophthalmic Solutions
KW  - Prospective Studies
KW  - Quinolones
KW  - Staphylococcal Infections
KW  - Streptococcal Infections
KW  - Tobramycin
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1159/000027430
ER  -